Showing results (121-130 of 171) with videos related to
Sort By:
Pageof 18
The Lancet. Gastroenterology & Hepatology|November 19, 2021
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trialsDavid T Rubin, Iris Dotan, Aaron DuVall, et al.Crohn'S & Colitis 360|February 13, 2023
Development of a New Index to Assess Small Bowel Inflammation Severity in Crohn's Disease Using Magnetic Resonance EnterographyYoram Bouhnik, Catherine Le Berre, Magaly Zappa, et al.Journal of Crohn'S & Colitis|October 5, 2023
Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAIDMathieu Uzzan, Maria Nachury, Alexandre Nuzzo, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2019
Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative ProctitisGuillaume Pineton de Chambrun, Aurélien Amiot, Guillaume Bouguen, et al.Gastroenterology|September 28, 2011
Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stoppedEdouard Louis, Jean-Yves Mary, Gwenola Vernier-Massouille, et al.The Journal of Experimental Medicine|January 2, 2008
Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac diseaseTamara Matysiak-Budnik, Ivan Cruz Moura, Michelle Arcos-Fajardo, et al.Journal of Crohn'S & Colitis|October 18, 2023
Lymphoma in Patients with Inflammatory Bowel Disease: A Multicentre Collaborative Study Between GETAID and LYSAMarie Muller, Julien Broséus, Adrien Guilloteau, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 29, 2021
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX TrialDavid Laharie, Geert D'Haens, Maria Nachury, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 4, 2015
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor AgentsPauline Wils, Yoram Bouhnik, Pierre Michetti, et al.Gastroenterology|November 19, 2008
Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type IIGeorgia Malamut, Pauline Afchain, Virginie Verkarre, et al.Pageof 18